한글목차

세계 mRNA 생효소 시장 규모는 2023년 17억 6,710만 달러에 달했습니다.

이 시장은 2030년 17억 3,122만 달러에 달할 것으로 예상되며, 예측 기간인 2024-2030년 CAGR은 1.42%에 달할 것으로 예측됩니다.

북미 mRNA 생효소 시장 규모는 2023년 6억 4,010만 달러에 달했습니다. 이 시장은 2024-2030년 예측 기간 동안 -0.67%의 CAGR로 2030년까지 6억 1,493만 달러에 달할 것으로 예상됩니다.

아시아태평양의 mRNA 생효소 시장 규모는 2023년 3억 6,791만 달러에 달했습니다. 이 시장은 2024-2030년 예측 기간 동안 4.83%의 CAGR로 성장하여 2030년에는 4억 6,847만 달러에 달할 것으로 예상됩니다.

유럽의 mRNA 생효소 시장 규모는 2023년 5억 9,233만 달러에 달했습니다. 이 시장은 2024년부터 2030년까지 예측 기간 동안 1.44%의 CAGR로 성장하여 2030년까지 5억 6,594만 달러에 달할 것으로 예상됩니다.

이 보고서는 세계 mRNA 생효소 시장을 조사하여 시장 개요와 함께 유형별, 용도별, 지역별 동향, 시장 진입 기업 개요 등을 제공합니다.

목차

제1장 mRNA 생효소 시장 개요

• mRNA 생효소 시장 개요
• 세계의 mRNA 생효소 시장 규모 개요(지역별) 2019년 VS 2023년 VS 2030년
• 세계의 mRNA 생효소 시장 규모(지역별)(2019-2030년)
• 주요 지역의 mRNA 생효소 시장 규모(2019-2030년)

제2장 mRNA 생효소 시장(유형별)

• 소개
• 세계의 mRNA 생효소 시장 규모(유형별) : 2019년 대 2023년 대 2030년
• 주요 지역의 시장 규모(유형별)

제3장 mRNA 생효소 시장 개요

• 소개
• 세계의 mRNA 생효소 시장 규모(용도별) : 2019년 VS 2023년 VS 2030년
• 주요 지역의 시장 규모(용도별)

제4장 진출 기업에 의한 mRNA 생효소 경쟁 분석

제5장 주요 기업 개요

• Thermo Fisher
• NEB
• TriLink Bio Technologies
• Merck
• Aldevron
• Qiagen NV
• Promega
• Roche CustomBiotech
• Takara Bio Inc
• Novoprotein
• Vazyme
• Hongene Biotech Corporatio
• Yeasen Biotechnology(Shanghai)
• Kactus Biosystems

제6장 북미

제7장 유럽

제8장 아시아태평양

제9장 라틴아메리카

제10장 중동 및 아프리카

제11장 mRNA 생효소 시장 역학

제12장 조사 결과/결론

제13장 조사 방법과 정보 출처

영문목차

The global market for mRNA Raw Enzyme estimated was at US$ 1767.10 million in the year 2023, is projected to reach a revised size of US$ 1,731.22 million by 2030, growing at a CAGR of 1.42% during the forecast period 2024-2030.

North American market for mRNA Raw Enzyme was valued at $ 640.10 million in 2023 and will reach $ 614.93 million by 2030, at a CAGR of -0.67% during the forecast period of 2024 through 2030.

Asia-Pacific market for mRNA Raw Enzyme was valued at $ 367.91 million in 2023 and will reach $ 468.47 million by 2030, at a CAGR of 4.83% during the forecast period of 2024 through 2030.

Europe market for mRNA Raw Enzyme was valued at $ 592.33 million in 2023 and will reach $ 565.94 million by 2030, at a CAGR of 1.44% during the forecast period of 2024 through 2030.

This report aims to provide a comprehensive presentation of the global market for mRNA Raw Enzyme, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Raw Enzyme.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA Raw Enzyme market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation

This report covers the mRNA Raw Enzyme segments by company, by Type, by Application, by region and country, and provides market size and CAGR for the history and forecast period (2019-2024, 2025-2030), considering 2023 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

By Company

• Thermo Fisher
• NEB
• TriLink Bio Technologies
• Merck
• Aldevron
• Qiagen N.V.
• Promega
• Roche CustomBiotech
• Takara Bio Inc
• Novoprotein
• Vazyme
• Hongene Biotech Corporatio
• Yeasen Biotechnology (Shanghai)
• Kactus Biosystems

Segment by Type

• Capping Enzyme
• 2'-O-Methyltransferase
• Inorganic Pyrophosphatase
• Poly (A) Polymerase
• Rnase Inhibitor
• RNA Polymerase
• Restriction Enzyme
• Dnase I
• Others

Segment by Application

• Biopharmaceutical Companies
• Academic and Research Institutes

By Region

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• Japan
• South Korea
• India
• Australia
• Southeast Asia
• Asia-Pacific Other
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Europe Other
• Latin America
• Brazil
• Argentina
• Latin America Other
• Middle East & Africa
• Middle East
• Africa

Chapter Outline

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter Four: Detailed analysis of mRNA Raw Enzyme companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.

Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Research Finding/Conclusion

Table of Contents

1 Market Overview of mRNA Raw Enzyme

• 1.1 mRNA Raw Enzyme Market Overview
  • 1.1.1 mRNA Raw Enzyme Product Scope
  • 1.1.2 mRNA Raw Enzyme Market Status and Outlook
• 1.2 Global mRNA Raw Enzyme Market Size Overview by Region 2019 VS 2023 VS 2030
• 1.3 Global mRNA Raw Enzyme Market Size by Region (2019-2030)
  • 1.3.1 Global mRNA Raw Enzyme Historic Market Size by Region (2019-2024)
  • 1.3.2 Global mRNA Raw Enzyme Market Size Forecast by Region (2025-2030)
• 1.4 Key Regions mRNA Raw Enzyme Market Size (2019-2030)
  • 1.4.1 North America mRNA Raw Enzyme Market Size (2019-2030)
  • 1.4.2 Europe mRNA Raw Enzyme Market Size (2019-2030)
  • 1.4.3 Asia-Pacific mRNA Raw Enzyme Market Size (2019-2030)
  • 1.4.4 Latin America mRNA Raw Enzyme Market Size (2019-2030)
  • 1.4.5 Middle East & Africa mRNA Raw Enzyme Market Size (2019-2030)

2 mRNA Raw Enzyme Market by Type

• 2.1 Introduction
  • 2.1.1 Capping Enzyme
  • 2.1.2 2'-O-Methyltransferase
  • 2.1.3 Inorganic Pyrophosphatase
  • 2.1.4 Poly (A) Polymerase
  • 2.1.5 Rnase Inhibitor
  • 2.1.6 RNA Polymerase
  • 2.1.7 Restriction Enzyme
  • 2.1.8 Dnase I
  • 2.1.9 Others
• 2.2 Global mRNA Raw Enzyme Market Size by Type: 2019 VS 2023 VS 2030
  • 2.2.1 Global mRNA Raw Enzyme Historic Market Size by Type (2019-2024)
  • 2.2.2 Global mRNA Raw Enzyme Forecasted Market Size by Type (2025-2030)
• 2.3 Key Regions Market Size by Type
  • 2.3.1 North America mRNA Raw Enzyme Revenue Breakdown by Type (2019-2030)
  • 2.3.2 Europe mRNA Raw Enzyme Revenue Breakdown by Type (2019-2030)
  • 2.3.3 Asia-Pacific mRNA Raw Enzyme Revenue Breakdown by Type (2019-2030)
  • 2.3.4 Latin America mRNA Raw Enzyme Revenue Breakdown by Type (2019-2030)
  • 2.3.5 Middle East and Africa mRNA Raw Enzyme Revenue Breakdown by Type (2019-2030)

3 mRNA Raw Enzyme Market Overview by Application

• 3.1 Introduction
  • 3.1.1 Biopharmaceutical Companies
  • 3.1.2 Academic and Research Institutes
• 3.2 Global mRNA Raw Enzyme Market Size by Application: 2019 VS 2023 VS 2030
  • 3.2.1 Global mRNA Raw Enzyme Historic Revenue by Application (2019-2024)
  • 3.2.2 Global mRNA Raw Enzyme Forecasted Revenue by Application (2025-2030)
• 3.3 Key Regions Market Size by Application
  • 3.3.1 North America mRNA Raw Enzyme Revenue Breakdown by Application (2019-2030)
  • 3.3.2 Europe mRNA Raw Enzyme Revenue Breakdown by Application (2019-2030)
  • 3.3.3 Asia-Pacific mRNA Raw Enzyme Revenue Breakdown by Application (2019-2030)
  • 3.3.4 Latin America mRNA Raw Enzyme Revenue Breakdown by Application (2019-2030)
  • 3.3.5 Middle East and Africa mRNA Raw Enzyme Revenue Breakdown by Application (2019-2030)

4 mRNA Raw Enzyme Competition Analysis by Players

• 4.1 Global mRNA Raw Enzyme Market Size by Players (2019-2024)
• 4.2 Global Top Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Raw Enzyme as of 2023)
• 4.3 Global Key Players of mRNA Raw Enzyme Head office and Area Served
• 4.4 Global Key Players of mRNA Raw Enzyme Product
• 4.5 Global Key Players of mRNA Raw Enzyme Established Year
• 4.6 Competitive Status
  • 4.6.1 mRNA Raw Enzyme Market Concentration Rate
  • 4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

• 5.1 Thermo Fisher
  • 5.1.1 Thermo Fisher Profile
  • 5.1.2 Thermo Fisher Main Business
  • 5.1.3 Thermo Fisher mRNA Raw Enzyme Products, Services and Solutions
  • 5.1.4 Thermo Fisher mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024)
  • 5.1.5 Thermo Fisher Recent Developments
• 5.2 NEB
  • 5.2.1 NEB Profile
  • 5.2.2 NEB Main Business
  • 5.2.3 NEB mRNA Raw Enzyme Products, Services and Solutions
  • 5.2.4 NEB mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024)
  • 5.2.5 NEB Recent Developments
• 5.3 TriLink Bio Technologies
  • 5.3.1 TriLink Bio Technologies Profile
  • 5.3.2 TriLink Bio Technologies Main Business
  • 5.3.3 TriLink Bio Technologies mRNA Raw Enzyme Products, Services and Solutions
  • 5.3.4 TriLink Bio Technologies mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024)
  • 5.3.5 TriLink Bio Technologies Recent Developments
• 5.4 Merck
  • 5.4.1 Merck Profile
  • 5.4.2 Merck Main Business
  • 5.4.3 Merck mRNA Raw Enzyme Products, Services and Solutions
  • 5.4.4 Merck mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024)
  • 5.4.5 Merck Recent Developments
• 5.5 Aldevron
  • 5.5.1 Aldevron Profile
  • 5.5.2 Aldevron Main Business
  • 5.5.3 Aldevron mRNA Raw Enzyme Products, Services and Solutions
  • 5.5.4 Aldevron mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024)
  • 5.5.5 Aldevron Recent Developments
• 5.6 Qiagen N.V.
  • 5.6.1 Qiagen N.V. Profile
  • 5.6.2 Qiagen N.V. Main Business
  • 5.6.3 Qiagen N.V. mRNA Raw Enzyme Products, Services and Solutions
  • 5.6.4 Qiagen N.V. mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024)
  • 5.6.5 Qiagen N.V. Recent Developments
• 5.7 Promega
  • 5.7.1 Promega Profile
  • 5.7.2 Promega Main Business
  • 5.7.3 Promega mRNA Raw Enzyme Products, Services and Solutions
  • 5.7.4 Promega mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024)
• 5.8 Roche CustomBiotech
  • 5.8.1 Roche CustomBiotech Profile
  • 5.8.2 Roche CustomBiotech Main Business
  • 5.8.3 Roche CustomBiotech mRNA Raw Enzyme Products, Services and Solutions
  • 5.8.4 Roche CustomBiotech mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024)
  • 5.8.5 Roche CustomBiotech Recent Developments
• 5.9 Takara Bio Inc
  • 5.9.1 Takara Bio Inc Profile
  • 5.9.2 Takara Bio Inc Main Business
  • 5.9.3 Takara Bio Inc mRNA Raw Enzyme Products, Services and Solutions
  • 5.9.4 Takara Bio Inc mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024)
  • 5.9.5 Takara Bio Inc Recent Developments
• 5.10 Novoprotein
  • 5.10.1 Novoprotein Profile
  • 5.10.2 Novoprotein Main Business
  • 5.10.3 Novoprotein mRNA Raw Enzyme Products, Services and Solutions
  • 5.10.4 Novoprotein mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024)
  • 5.10.5 Novoprotein Recent Developments
• 5.11 Vazyme
  • 5.11.1 Vazyme Profile
  • 5.11.2 Vazyme Main Business
  • 5.11.3 Vazyme mRNA Raw Enzyme Products, Services and Solutions
  • 5.11.4 Vazyme mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024)
  • 5.11.5 Vazyme Recent Developments
• 5.12 Hongene Biotech Corporatio
  • 5.12.1 Hongene Biotech Corporatio Profile
  • 5.12.2 Hongene Biotech Corporatio Main Business
  • 5.12.3 Hongene Biotech Corporatio mRNA Raw Enzyme Products, Services and Solutions
  • 5.12.4 Hongene Biotech Corporatio mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024)
  • 5.12.5 Hongene Biotech Corporatio Recent Developments
• 5.13 Yeasen Biotechnology (Shanghai)
  • 5.13.1 Yeasen Biotechnology (Shanghai) Profile
  • 5.13.2 Yeasen Biotechnology (Shanghai) Main Business
  • 5.13.3 Yeasen Biotechnology (Shanghai) mRNA Raw Enzyme Products, Services and Solutions
  • 5.13.4 Yeasen Biotechnology (Shanghai) mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024)
  • 5.13.5 Yeasen Biotechnology (Shanghai) Recent Developments
• 5.14 Kactus Biosystems
  • 5.14.1 Kactus Biosystems Profile
  • 5.14.2 Kactus Biosystems Main Business
  • 5.14.3 Kactus Biosystems mRNA Raw Enzyme Products, Services and Solutions
  • 5.14.4 Kactus Biosystems mRNA Raw Enzyme Revenue (US$ Million) & (2019-2024)
  • 5.14.5 Kactus Biosystems Recent Developments

6 North America

• 6.1 North America mRNA Raw Enzyme Market Size by Country (2019-2030)
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe

• 7.1 Europe mRNA Raw Enzyme Market Size by Country (2019-2030)
• 7.2 Germany
• 7.3 France
• 7.4 U.K.
• 7.5 Italy
• 7.6 Russia
• 7.7 Europe Other

8 Asia-Pacific

• 8.1 Asia-Pacific mRNA Raw Enzyme Market Size by Region (2019-2030)
• 8.2 China
• 8.3 Japan
• 8.4 South Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australia
• 8.8 Asia Pacific Other

9 Latin America

• 9.1 Latin America mRNA Raw Enzyme Market Size by Country (2019-2030)
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Latin America Other

10 Middle East & Africa

• 10.1 Middle East & Africa mRNA Raw Enzyme Market Size
• 10.2 Middle East
• 10.3 Africa

11 mRNA Raw Enzyme Market Dynamics

• 11.1 mRNA Raw Enzyme Industry Trends
• 11.2 mRNA Raw Enzyme Market Drivers
• 11.3 mRNA Raw Enzyme Market Challenges
• 11.4 mRNA Raw Enzyme Market Restraints

12 Research Finding/Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List
• 13.4 Disclaimer